CAS: 144-87-6; [4-[(2-Hydroxyacetyl)Amino]Phenyl]Arsonic Acid
该化合物是有机精质化合物,主要用于兽医和农业,作为家禽和猪的饲料添加剂,似乎是白到白的晶状粉,在水中可溶解,便于在动物饲料中应用,含有砷原子,附着在芳香环上,有助于生物活动,对罗克松具有促进牲畜生长和提高饲料效率的潜力进行了研究,尽管对动物组织和环境中砷积累的关切已引起人们对其安全和监管状况的疑问,该化合物的结构包括诸如氨基氨基基化合物和氢氧基化合物等功能组,这可能影响其在生物系统中的回作用和相互作用,由于其含砷含量,罗克龙素在许多国家受到严格管制,而且已根据与砷接触相关的潜在健康风险对其使用情况进行了审查.
- 英文名称[4-[(2-Hydroxyacetyl)Amino]Phenyl]Arsonic Acid
- 中文名称4-(羟基乙酰基氨基)苯胂酸
- 其它别名Arsanilic acid,N-glycoloyl- (8CI); Arsonic acid, [4-[(hydroxyacetyl)amino]phenyl]- (9CI); Astryl; Glycarsamide; Glycarsiamidon; N-Glycoloylarsanilic acid; p-(Glycoloylamino)benzenearsonic acid; p-(Glycoloylamino)phenylarsonic acid; p-(Hydroxyacetamido)phenylarsonic acid
- CAS编号144-87-6
- MFCD编号:MFCD00068960
- EINECS号:205-643-2
- FDA UNII编号:3ACA67L6DG
- 分子式:C8H10AsNO5分子量:275.093
- 产品CID: 684054
- 产品分类有机原料 → 苯类化合物 → 苯取代衍生物
MSDS等安全信息
- 警示词warning
- 危险描述H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- 防范说明P264Thoroughly clean after treatmentP280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective maskP305If it enters the eyesP351Rinse carefully with water for a few minutesP338Remove the contact lens(If any)And easy to operate,Continue flushingP337If eye irritation persistsP313Obtain medical advice/care
- 安全声明H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
上下游产品
4-(2-氯乙酰氨基)苯基砷酸 4-Chloracetamido-Phenylarsonsaeure 5425-62-7对氨基苯砷酸 P-Aminophenylarsonic Acid 98-50-0
合成工艺路线路线简述
📜4-(2-氯乙酰氨基)苯基砷酸置于sodium Hydroxide体系中,化学反应生成4-(羟基乙酰基氨基)苯胂酸
参考文献:De513210
标题:De513210
海关参考信息
- 2912110000-甲醛
2912120000-乙醛
2922110001-单乙醇胺
2924199090-其他无环酰胺 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2006247308-A1
优先权日:1999-05-14
标 题:Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
发明人：KATZ STANLEY E; MARTIN ALAIN
权利人:KATZ STANLEY E; MARTIN ALAIN
摘要:A method for treating the disease state in mammals caused by mammalian nasal and sinus cells involved in the inflammatory response is disclosed. Mammalian nasal and sinus cells participating in the inflammatory response are contacted with an inflammatory response mediator which reduces the undesired inflammatory response and is an antioxidant. The inflammatory response mediator may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response are also disclosed.
专利号:EP-1183022-B1
优先权日:1999-05-14
标题 :Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
发明人：KATZ STANLEY E; MARTIN ALAIN
权利人:CELLULAR SCIENCES INC
摘要:A method for treating the disease state in mammals caused by a mammalian nasal and sinus cells involved in the inflammatory responser is disclosed. Mammalian nasal and sinus cells participating in the inflammatory response are contacted with an inflammatory response mediator which reduces the undesired inflammatory response and is an antioxidant. The inflammatory response mediator may further provide a cellular energy source and be a building block in the cellular synthesis of other cellular components. Compositions for reducing and treating undesired inflammatory response are also disclosed.
专利号:US-10590088-B2
优先权日:2009-06-23
标 题:4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:https://echa.europa.eu/substances-restricted-under-reach
📝 需求与反馈
尽可能描述清楚需求与问题信息
